Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cicaderma is a homeopathic ointment developed by Boiron, traditionally used for the treatment of skin irritations, superficial burns, and small wounds. It is a multi-ingredient formulation containing extracts of *Calendula officinalis*, *Hypericum perforatum*, *Achillea millefolium*, *Ledum palustre*, and *Pulsatilla*. In clinical research, it is being evaluated for its efficacy in preventing grade 2 or higher radiodermatitis in patients undergoing adjuvant radiotherapy for non-metastatic breast cancer. The ointment acts as a protective barrier and emollient, leveraging the anti-inflammatory and wound-healing properties attributed to its botanical components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cicaderma (Boiron).